Elite Pharms Inc (ELTP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 03-2011 | 03-2010 | 03-2009 | 03-2008 | 03-2007 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,826 | 578 | 283 | 3,703 | 812 |
| Receivables | 572 | 405 | 1 | 149 | 216 |
| Inventories | 616 | 1,371 | 1,704 | 2,124 | 813 |
| TOTAL | $3,147 | $2,486 | $2,319 | $6,154 | $2,147 |
| Non-Current Assets | |||||
| PPE Net | 4,118 | 4,096 | 4,576 | 5,009 | 4,862 |
| Investments And Advances | 3,329 | 3,329 | 3,329 | 3,329 | 1,368 |
| Intangibles | 598 | 96 | 28 | 35 | 43 |
| Other Non-Current Assets | 595 | 599 | 669 | 784 | 789 |
| TOTAL | $8,641 | $8,121 | $8,601 | $9,157 | $7,061 |
| Total Assets | $11,788 | $10,607 | $10,920 | $15,310 | $9,208 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 3,398 | 3,385 | 210 | 210 | 185 |
| Accounts payable and accrued liabilities | 936 | 987 | 981 | 850 | 1,718 |
| Accrued Expenses | 283 | 306 | N/A | N/A | N/A |
| Other current liabilities | 39 | N/A | N/A | N/A | N/A |
| TOTAL | $4,669 | $4,761 | $1,561 | $1,124 | $1,903 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 20 | 3,417 | 3,637 | 3,795 |
| Deferred Revenues | 13 | N/A | N/A | N/A | N/A |
| Other Non-Current Liabilities | 24,811 | 16,424 | 0 | 0 | 0 |
| TOTAL | $24,990 | $16,444 | $3,417 | $3,637 | $3,795 |
| Total Liabilities | $29,659 | $21,205 | $4,977 | $4,761 | $5,698 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 243,364 | 87,353 | 69,970 | 23,232 | 20,820 |
| Common Shares | 181 | 84 | 608 | 231 | 208 |
| Retained earnings | -114,861 | -101,279 | -90,002 | -81,190 | -62,811 |
| Other shareholders' equity | -307 | -307 | -382 | -382 | -382 |
| TOTAL | $-17,871 | $-10,598 | $5,943 | $10,549 | $3,511 |
| Total Liabilities And Equity | $11,788 | $10,607 | $10,920 | $15,310 | $9,208 |